|
1
|
Dental x-rays and risk of meningioma.
|
Cancer
|
2012
|
5.99
|
|
2
|
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
|
Lancet Oncol
|
2012
|
5.70
|
|
3
|
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
|
Nat Genet
|
2009
|
4.38
|
|
4
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
|
Nat Genet
|
2013
|
4.35
|
|
5
|
Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
|
J Clin Oncol
|
2006
|
3.73
|
|
6
|
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
Nat Genet
|
2013
|
3.42
|
|
7
|
Epidemiology of intracranial meningioma.
|
Neurosurgery
|
2005
|
2.60
|
|
8
|
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
|
J Natl Cancer Inst
|
2014
|
2.40
|
|
9
|
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
|
Clin Cancer Res
|
2011
|
2.09
|
|
10
|
Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke.
|
Gene
|
2011
|
2.03
|
|
11
|
Validity of models for predicting BRCA1 and BRCA2 mutations.
|
Ann Intern Med
|
2007
|
1.94
|
|
12
|
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
|
Nat Commun
|
2013
|
1.73
|
|
13
|
BAYESIAN MODEL SEARCH AND MULTILEVEL INFERENCE FOR SNP ASSOCIATION STUDIES.
|
Ann Appl Stat
|
2010
|
1.66
|
|
14
|
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
|
Cancer Res
|
2011
|
1.64
|
|
15
|
Racial differences in enrolment in a cancer genetics registry.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.62
|
|
16
|
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
|
Am J Obstet Gynecol
|
2004
|
1.62
|
|
17
|
Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy.
|
Epigenetics
|
2011
|
1.60
|
|
18
|
Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls.
|
Gynecol Oncol
|
2003
|
1.55
|
|
19
|
Ovarian cancer risk factors in African-American and white women.
|
Am J Epidemiol
|
2009
|
1.49
|
|
20
|
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
|
PLoS Genet
|
2010
|
1.47
|
|
21
|
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.
|
Am J Epidemiol
|
2008
|
1.46
|
|
22
|
Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort.
|
BMC Med
|
2013
|
1.44
|
|
23
|
Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
|
Cancer Res
|
2008
|
1.42
|
|
24
|
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.
|
Hum Mol Genet
|
2009
|
1.42
|
|
25
|
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
|
Nat Commun
|
2013
|
1.36
|
|
26
|
Role of genetic polymorphisms and ovarian cancer susceptibility.
|
Mol Oncol
|
2009
|
1.33
|
|
27
|
Performance of amplified DNA in an Illumina GoldenGate BeadArray assay.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.32
|
|
28
|
Inherited determinants of ovarian cancer survival.
|
Clin Cancer Res
|
2010
|
1.32
|
|
29
|
Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST).
|
BMC Public Health
|
2011
|
1.29
|
|
30
|
Effect of hysterectomy with ovarian preservation on ovarian function.
|
Obstet Gynecol
|
2011
|
1.28
|
|
31
|
Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight.
|
Cancer Causes Control
|
2012
|
1.27
|
|
32
|
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.26
|
|
33
|
Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.25
|
|
34
|
Global ovarian cancer health disparities.
|
Gynecol Oncol
|
2012
|
1.24
|
|
35
|
Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.
|
J Gen Intern Med
|
2005
|
1.22
|
|
36
|
Exogenous hormone use and meningioma risk: what do we tell our patients?
|
Cancer
|
2007
|
1.20
|
|
37
|
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
|
Clin Cancer Res
|
2003
|
1.19
|
|
38
|
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.
|
Cancer Res
|
2008
|
1.17
|
|
39
|
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
|
Int J Cancer
|
2011
|
1.17
|
|
40
|
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
|
Int J Gynecol Cancer
|
2012
|
1.14
|
|
41
|
Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).
|
Cancer Causes Control
|
2002
|
1.14
|
|
42
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.14
|
|
43
|
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.11
|
|
44
|
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.
|
Int J Epidemiol
|
2013
|
1.10
|
|
45
|
Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium.
|
Adv Exp Med Biol
|
2008
|
1.10
|
|
46
|
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.08
|
|
47
|
Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women.
|
Cancer Causes Control
|
2005
|
1.08
|
|
48
|
Flexible Frames and Control Sampling in Case-Control Studies: Weighters (Survey Statisticians) Versus Anti-Weighters (Epidemiologists).
|
Am Stat
|
2008
|
1.07
|
|
49
|
Pre-counseling education materials for BRCA testing: does tailoring make a difference?
|
Genet Test
|
2002
|
1.04
|
|
50
|
Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues.
|
Gynecol Oncol
|
2012
|
1.03
|
|
51
|
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.02
|
|
52
|
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.01
|
|
53
|
Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.99
|
|
54
|
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
|
Hum Genet
|
2013
|
0.99
|
|
55
|
Recreational physical activity and ovarian cancer risk and survival.
|
Ann Epidemiol
|
2011
|
0.99
|
|
56
|
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.98
|
|
57
|
Ovarian cancer risk associated with inherited inflammation-related variants.
|
Cancer Res
|
2012
|
0.98
|
|
58
|
Family and personal medical history and risk of meningioma.
|
J Neurosurg
|
2011
|
0.97
|
|
59
|
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls.
|
Int J Cancer
|
2011
|
0.96
|
|
60
|
Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.
|
J Neurosurg
|
2012
|
0.95
|
|
61
|
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.94
|
|
62
|
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
|
BMC Cancer
|
2009
|
0.93
|
|
63
|
Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
|
PLoS One
|
2013
|
0.93
|
|
64
|
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.92
|
|
65
|
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.92
|
|
66
|
Survival and low-grade glioma: the emergence of genetic information.
|
Neurosurg Focus
|
2015
|
0.91
|
|
67
|
Risk of ovarian cancer and inherited variants in relapse-associated genes.
|
PLoS One
|
2010
|
0.90
|
|
68
|
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
|
Cancer Causes Control
|
2012
|
0.90
|
|
69
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.89
|
|
70
|
Menopausal hormones and risk of ovarian cancer.
|
Am J Obstet Gynecol
|
2005
|
0.89
|
|
71
|
Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.
|
Cancer Causes Control
|
2010
|
0.89
|
|
72
|
Germline copy number variation and ovarian cancer survival.
|
Front Genet
|
2012
|
0.88
|
|
73
|
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
|
Twin Res Hum Genet
|
2010
|
0.87
|
|
74
|
Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites.
|
J Natl Med Assoc
|
2007
|
0.87
|
|
75
|
Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.
|
J Natl Med Assoc
|
2009
|
0.86
|
|
76
|
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
|
Mol Carcinog
|
2010
|
0.86
|
|
77
|
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.86
|
|
78
|
Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
|
PLoS One
|
2009
|
0.86
|
|
79
|
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.
|
Breast Cancer Res Treat
|
2010
|
0.85
|
|
80
|
Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
|
Gynecol Oncol
|
2012
|
0.85
|
|
81
|
Activating mutation in MET oncogene in familial colorectal cancer.
|
BMC Cancer
|
2011
|
0.85
|
|
82
|
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
|
Hum Mol Genet
|
2011
|
0.85
|
|
83
|
Cigarette smoking and risk of meningioma: the effect of gender.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.84
|
|
84
|
A prospective study of weight gain after premenopausal hysterectomy.
|
J Womens Health (Larchmt)
|
2009
|
0.84
|
|
85
|
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|
|
86
|
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.84
|
|
87
|
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.
|
PLoS One
|
2011
|
0.83
|
|
88
|
Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.
|
Gynecol Oncol
|
2005
|
0.83
|
|
89
|
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
|
Cancer Immunol Res
|
2014
|
0.82
|
|
90
|
Reported symptoms before and one year after hysterectomy in African American and white women.
|
J Womens Health (Larchmt)
|
2011
|
0.82
|
|
91
|
Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.
|
Genet Test Mol Biomarkers
|
2012
|
0.81
|
|
92
|
Common variation in Nemo-like kinase is associated with risk of ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.80
|
|
93
|
Antidepressant medication use [corrected] and risk of ovarian cancer.
|
Obstet Gynecol
|
2005
|
0.80
|
|
94
|
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
|
BMC Cancer
|
2013
|
0.80
|
|
95
|
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
|
Obstet Gynecol
|
2016
|
0.80
|
|
96
|
IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites.
|
Dis Markers
|
2012
|
0.79
|
|
97
|
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.
|
Fertil Steril
|
2010
|
0.79
|
|
98
|
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
|
Int J Cancer
|
2009
|
0.78
|
|
99
|
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
|
PLoS One
|
2011
|
0.78
|
|
100
|
Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants.
|
Int J Pediatr
|
2013
|
0.78
|
|
101
|
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
|
Mol Nutr Food Res
|
2014
|
0.77
|
|
102
|
Socioeconomic Status in Relation to the Risk of Ovarian Cancer in African-American Women: A Population-Based Case-Control Study.
|
Am J Epidemiol
|
2016
|
0.76
|
|
103
|
European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry.
|
PLoS One
|
2012
|
0.76
|
|
104
|
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.
|
Front Genet
|
2012
|
0.76
|
|
105
|
Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
|
BMC Cancer
|
2013
|
0.76
|
|
106
|
Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.75
|
|
107
|
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
|
Am J Epidemiol
|
2016
|
0.75
|
|
108
|
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
|
Am J Epidemiol
|
2016
|
0.75
|
|
109
|
Endometrial cancer.
|
Gynecol Oncol
|
2011
|
0.75
|
|
110
|
Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.
|
Am J Epidemiol
|
2017
|
0.75
|
|
111
|
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.
|
Am J Epidemiol
|
2017
|
0.75
|
|
112
|
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.
|
Int J Epidemiol
|
2017
|
0.75
|